Difference between revisions of "Team:British Columbia"

Line 1: Line 1:
−
{{British_Columbia/CSS}}
 
 
{{British_Columbia/Header}}
 
{{British_Columbia/Header}}
 +
{{British_Columbia/CSS}}
 +
  
 
<html>
 
<html>
 
<body>
 
<body>
  
−
<h1>UBC iGEM 2018: Distributed Metabolic Pathway of Naringenin</h1>
+
<h1 style="color: #45827A;
−
<p><div>Dividing metabolism amongst microbial communities has shown huge potential for the large-scale production of chemical products. Unfortunately, optimizing the population dynamics of the individual strain modules remains a challenge (Jones & Wang, 2018). Our goal is to improve the production of naringenin and its pharmaceutically significant derivatives, which have anti-cancer and anti-inflammatory properties, by distributing the synthesis of a naringenin derivative between two E. coli strains and optimizing their relative proportions in co-culture. One strain will produce naringenin from glucose and the second strain will create the naringenin derivative. We will regulate the ratio of the two strains using a biosensor and a toehold switch. This will couple cell growth with the concentration of naringenin, allowing the co-culture to self-optimize and increase naringenin production. Using our system, we will have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds.</div></p>
+
text-align: center;
 +
font-family: GeosansLight;
 +
-webkit-text-stroke: 1px;
 +
font-size: 30px;
 +
letter-spacing: 1.5px;
 +
margin-top: 40px;">UBC iGEM 2018: Distributed Metabolic Pathway of Naringenin</h1>
 +
 
 +
<p style="color: #585858;
 +
font-family: GeosansLight;
 +
text-align: left;
 +
-webkit-text-stroke: 0.5px;
 +
font-size: 17px;
 +
margin-left: 60px;
 +
margin-right: 70px;">Dividing metabolism amongst microbial communities has shown huge potential for the large-scale production of chemical products. Unfortunately, optimizing the population dynamics of the individual strain modules remains a challenge (Jones & Wang, 2018). Our goal is to improve the production of naringenin and its pharmaceutically significant derivatives, which have anti-cancer and anti-inflammatory properties, by distributing the synthesis of a naringenin derivative between two E. coli strains and optimizing their relative proportions in co-culture. One strain will produce naringenin from glucose and the second strain will create the naringenin derivative. We will regulate the ratio of the two strains using a biosensor and a toehold switch. This will couple cell growth with the concentration of naringenin, allowing the co-culture to self-optimize and increase naringenin production. Using our system, we will have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds.</p>
 +
 
  
 
</body>
 
</body>
 
</html>
 
</html>

Revision as of 02:01, 20 August 2018

PROTOCOLS LAB BOOK
MEMBERS ATTRIBUTIONS SPONSORS
SILVER GOLD EDUCATION & ENGAGEMENT COLLABORATIONS
DESCRIPTION NARINGENIN BIOSENSOR KAEMPFEROL PARTS


UBC iGEM 2018: Distributed Metabolic Pathway of Naringenin

Dividing metabolism amongst microbial communities has shown huge potential for the large-scale production of chemical products. Unfortunately, optimizing the population dynamics of the individual strain modules remains a challenge (Jones & Wang, 2018). Our goal is to improve the production of naringenin and its pharmaceutically significant derivatives, which have anti-cancer and anti-inflammatory properties, by distributing the synthesis of a naringenin derivative between two E. coli strains and optimizing their relative proportions in co-culture. One strain will produce naringenin from glucose and the second strain will create the naringenin derivative. We will regulate the ratio of the two strains using a biosensor and a toehold switch. This will couple cell growth with the concentration of naringenin, allowing the co-culture to self-optimize and increase naringenin production. Using our system, we will have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds.